Patrick Forde

Prof. Patrick Forde is the Patrick Prendergast Professor of Clinical Immuno-Oncology at the Trinity St James’s Cancer Institute, Trinity College Dublin, and a Consultant Medical Oncologist at St James’s Hospital, Dublin. He led the development of neoadjuvant immunotherapy for resectable lung cancer from first-in-human proof of concept to global practice, serving as principal investigator of the CheckMate 816 trial that established neoadjuvant chemo-immunotherapy for stage II-III non-small cell lung cancer, and his work also extends to malignant pleural mesothelioma. He previously built this research program at Johns Hopkins University in Baltimore before moving to Dublin in 2024, and is a frequent speaker at major international thoracic oncology congresses.